Compounds > panipenem-betamipron
Page last updated: 2024-09-03

panipenem-betamipron and cefotaxime

panipenem-betamipron has been researched along with cefotaxime in 3 studies

Compound Research Comparison

Studies
(panipenem-betamipron)		Trials
(panipenem-betamipron)		Recent Studies (post-2010)
(panipenem-betamipron)		Studies
(cefotaxime)		Trials
(cefotaxime)		Recent Studies (post-2010) (cefotaxime)
681775,747727790

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Mine, S; Nakazaki, M; Ozaki, H; Saeki, N; Yamakami, I; Yamaura, A; Yoneyama, T1
Haruta, T; Nonoyama, M; Ouchi, K; Sakata, H; Sato, Y; Sunakawa, K; Yamaguchi, S1
Ishiwada, N; Nakamoto, T; Ohkusu, M; Sato, J; Shoji, T; Takahashi, K; Takei, H; Takeuchi, N; Yamada, N1

Other Studies

3 other study(ies) available for panipenem-betamipron and cefotaxime

ArticleYear
[Nocardial brain abscess: surgery and postoperative antibiotic therapy].
    No shinkei geka. Neurological surgery, 2004, Volume: 32, Issue:5

    Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; beta-Alanine; Brain Abscess; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drainage; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Immunocompromised Host; Lupus Erythematosus, Systemic; Male; Middle Aged; Minocycline; Nocardia Infections; Postoperative Care; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination

2004
[Pediatric bacterial meningitis prognosis and antibiotic treatment].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2011, Volume: 85, Issue:2

    Topics: Anti-Bacterial Agents; beta-Alanine; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Meningitis, Bacterial; Meropenem; Prognosis; Thienamycins

2011
Two cases of bacterial meningitis due to meropenem-resistant Streptococcus pneumoniae: A threat of serotype 35B, ST 558 lineage.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:7

    Topics: Anti-Bacterial Agents; beta-Alanine; Cefotaxime; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pneumococcal Vaccines; Serotyping; Streptococcus pneumoniae; Thienamycins; Treatment Outcome

2020